Brief Illness Perception Questionnaire (B-IPQ)

Abstract

The Brief Illness Perception Questionnaire (B-IPQ) is a widely utilized, nine-item psychometric instrument designed to rapidly assess cognitive and emotional representations of illness in clinical and research settings. Developed by Elizabeth Broadbent, Keith J. Petrie, Julie Main, and John Weinman in 2006, the scale provides a streamlined operationalization of Howard Leventhal’s Common-Sense Model of Self-Regulation (CSM). While its predecessor, the Revised Illness Perception Questionnaire (IPQ-R), comprises over 80 items across multiple subscales, the B-IPQ condenses these dimensions into eight single-item numerical rating scales (evaluated from 0 to 10 with item-specific anchors) and one qualitative, open-ended question assessing causal attributions. The eight continuous items evaluate specific core constructs: Consequences (Item 1), Timeline (Item 2), Personal Control (Item 3), Treatment Control (Item 4), Identity (Item 5), Concern (Item 6), Coherence/Understanding (Item 7), and Emotional Representation (Item 8). Item 9 requests that respondents list and rank the three primary causes they attribute to their condition. Psychometric evaluations across diverse medical populations—including myocardial infarction, chronic obstructive pulmonary disease (COPD), type 2 diabetes, end-stage renal disease, cancer, and chronic pain—demonstrate robust test-retest reliability (Pearson correlations ranging from r = .48 to .75 across intervals from 3 weeks to several months), excellent concurrent and convergent validity with the full IPQ-R subscales (correlations generally between r = .32 and .68), and high discriminant and predictive validity regarding treatment adherence, functional recovery, psychological distress, and mortality. An overall illness threat score can be derived by reverse-scoring the personal control, treatment control, and coherence items, yielding a composite score from 0 to 80, where higher scores reflect a more menacing or threatening cognitive and emotional representation of the illness.

Keywords

Brief Illness Perception Questionnaire, B-IPQ, Common-Sense Model of Self-Regulation, Illness Perceptions, Cognitive Representations, Emotional Representations, Health Psychology, Psychometrics, Medical Adherence, Chronic Illness

Authors

The Brief Illness Perception Questionnaire was developed by a team of prominent health psychologists and behavioral medicine researchers:

• Elizabeth Broadbent, Ph.D. — Professor of Health Psychology, School of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. Her research focuses on the impact of psychological factors on physical health, psychoneuroimmunology, patient illness perceptions, and human-robot interactions in healthcare settings.
• Keith J. Petrie, Ph.D. — Professor Emeritus of Health Psychology, Department of Psychological Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. Dr. Petrie is an internationally recognized authority on illness representations, symptom perception, medical adherence, and the nocebo effect.
• Julie Main, MBChB, FRACP — Consultant Renal Physician and Clinical Senior Lecturer, Department of Renal Medicine, Auckland City Hospital, Auckland, New Zealand. Her clinical research investigates psychological determinants of disease management and outcomes in chronic kidney disease and renal transplantation.
• John Weinman, Ph.D., FRCPE, FMedSci — Professor of Psychology as Applied to Medicine, Institute of Pharmaceutical Science and Department of Psychology, King’s College London, London, United Kingdom. As one of the founding figures of European health psychology, Professor Weinman co-developed the original Illness Perception Questionnaire (IPQ) and has published extensively on self-regulation in chronic medical illnesses.

Purpose

The Brief Illness Perception Questionnaire was designed to overcome the practical and psychometric limitations associated with administering extensive psychological batteries to physically ill, fatigued, or cognitively vulnerable patient populations. In epidemiological surveys, intensive hospital bedside consultations, acute clinical environments, and large-scale longitudinal clinical trials, administering lengthy multi-item scales such as the original 84-item IPQ-R imposes substantial respondent burden. This often leads to high rates of missing data, patient fatigue, and compromised data validity. The B-IPQ resolves these logistical challenges by delivering a rapid, five-minute assessment that retains the multi-dimensional breadth of the Common-Sense Model.

The fundamental theoretical rationale for measuring illness perceptions lies in the realization that patients do not respond passively to medical diagnoses or physiological symptoms. Instead, individuals actively formulate subjective mental models or cognitive “common-sense” schemas to make sense of their health threats. These implicit cognitive and emotional frameworks dictate coping mechanisms, health-seeking behaviors, medication adherence, physical rehabilitation attendance, dietary self-management, and clinical outcomes. For instance, a patient who perceives hypertension as an episodic condition that requires treatment only when symptoms like headaches emerge is significantly less likely to adhere to long-term antihypertensive therapy than a patient who understands the chronic, silent nature of vascular pathology.

From a clinical utility standpoint, the B-IPQ functions as an efficient diagnostic screener and a monitoring tool for therapeutic intervention. Clinicians can rapidly inspect item-level profiles to detect maladaptive beliefs—such as perceived lack of personal control (Item 3), pervasive functional pessimism (Item 1), or profound emotional distress (Item 8)—which can then be targeted using tailored cognitive behavioral therapy (CBT) or psychoeducational interventions. In empirical research, the B-IPQ serves as an indispensable instrument for evaluating how psychological representations moderate or mediate the relationship between objective physiological pathology and subjective health-related quality of life (HRQoL), disability, and healthcare utilization.

Psychological Construct

The B-IPQ operationalizes the core components of patient illness representations, conceptualized within cognitive and health psychology as multi-dimensional mental schemas. Each of the nine items maps directly onto a discrete theoretical domain:

• Consequences (Item 1): Assesses the patient’s cognitive appraisal of the anticipated and experienced repercussions of the condition on physical capabilities, occupational function, social relationships, and daily activities. A high score reflects the belief that the condition exerts profound, catastrophic, or disruptive consequences on daily life, which has been consistently associated with higher functional disability and depression.
• Timeline (Item 2): Evaluates the patient’s temporal expectation regarding disease chronicity versus transience. High scores denote a perception of the condition as permanent, lifelong, or unremitting, whereas low scores indicate a belief that the illness is acute, short-lived, or episodic. In conditions such as diabetes or asthma, an accurate chronic timeline model is essential for long-term preventive adherence.
• Personal Control (Item 3): Measures the individual’s perceived internal locus of control and self-efficacy regarding symptom management and disease stabilization. High scores reflect strong beliefs in one’s personal capability to influence symptoms, regulate lifestyle factors, and prevent disease progression.
• Treatment Control (Item 4): Gauges the patient’s external confidence in medical, surgical, or pharmacological interventions. High scores indicate strong faith in therapeutic efficacy, reflecting the belief that medications, therapies, or clinical recommendations will cure or effectively control the underlying illness.
• Identity (Item 5): Measures the subjective somatic symptom burden attributed directly to the diagnosed illness. This dimension reflects the degree to which a patient experiences frequent or severe physical sensations (e.g., fatigue, pain, dyspnea) and unequivocally labels them as manifestations of the pathological condition.
• Concern (Item 6): Evaluates the cognitive and affective worry, preoccupation, and cognitive intrusion caused by the health threat. High scores indicate continuous cognitive vigilance and intense distress regarding disease recurrence, complications, or progression.
• Coherence / Illness Comprehensibility (Item 7): Measures metacognitive appraisal of understanding. It evaluates whether the patient possesses a clear, integrated, and coherent mental representation of their pathology, or conversely, finds the disease baffling, mysterious, and unpredictable.
• Emotional Representation (Item 8): Captures the negative affective toll engendered by the medical diagnosis, directly tapping into feelings of anger, fright, depression, anxiety, or sorrow. High scores denote severe psychological reactivity secondary to somatic illness.
• Causal Attributions (Item 9): A qualitative, rank-ordered component where patients identify their three primary perceived causal mechanisms (e.g., genetic predisposition, stress, environmental toxins, diet, aging, or lifestyle choices). This qualitative profile illuminates implicit causal models that directly guide patient choices, including engagement with alternative medicine or lifestyle modifications.

Theoretical Framework

The theoretical architecture underpinning the B-IPQ is Howard Leventhal’s Common-Sense Model of Self-Regulation (CSM), also widely recognized in behavioral medicine as the self-regulatory model or parallel-processing model of illness. Formulated across decades of empirical work by Leventhal, Nerenz, Steele, and colleagues, the CSM posits that individuals are active, common-sense problem solvers who construct implicit dynamic representations to manage health threats.

According to the CSM, the self-regulatory system operates through three interactive stages:

1. Representation Stage (Parallel Processing): Upon encountering somatic stimuli (e.g., bodily sensations, pain, fatigue) or diagnostic medical information, the cognitive system activates two distinct, parallel pathways of representation: a cognitive representation (comprising the dimensional attributes of Identity, Timeline, Consequences, Cause, and Controllability) and an emotional representation (comprising affective responses such as fear, anger, vulnerability, and anxiety). The B-IPQ explicitly mirrors this dual-processing structure: Items 1–5 and 7 capture the cognitive schema, whereas Items 6 and 8 measure emotional distress and concern.
2. Coping and Action Plans: The patient selects behavioral coping strategies (e.g., taking prescribed medication, resting, altering diet, seeking second opinions, or engaging in behavioral avoidance) and emotional coping strategies (e.g., cognitive reappraisal, denial, venting) that are logically consistent with their subjective illness model. For example, if an individual conceptualizes hypertension purely through a somatic identity lens (“I only have high blood pressure when I feel dizzy”), their coping action plan will involve taking medication intermittently only during dizzy spells, directly contradicting clinical recommendations.
3. Appraisal Stage: The patient continuously evaluates the efficacy of their chosen coping actions against their initial illness schema. If a coping response fails to eliminate symptoms or restore functional equilibrium, the patient updates their cognitive representation, modifies their emotional state, or adjusts their behavioral coping strategies in an ongoing, cybernetic feedback loop.

The B-IPQ operationalizes this cybernetic system at a granular level, enabling health practitioners and behavioral researchers to determine precisely which node in the self-regulatory loop is generating maladaptive health outcomes.

Validity

Extensive psychometric investigations have established the construct, convergent, discriminant, and predictive validity of the B-IPQ across dozens of international medical samples, cultural contexts, and translated versions.

Concurrent and Convergent Validity: In the original validation study by Broadbent et al. (2006), the B-IPQ was administered alongside the full Revised Illness Perception Questionnaire (IPQ-R) in patients with renal disease, asthma, and myocardial infarction. Strong and statistically significant Pearson correlations emerged between the individual items of the B-IPQ and their corresponding multi-item subscales on the IPQ-R: Consequences (r = .59 to .68, p < .001), Timeline (r = .61 to .81, p < .001), Personal Control (r = .48 to .62, p < .001), Treatment Control (r = .42 to .54, p < .001), Identity (r = .62 to .71, p < .001), Coherence (r = .63 to .77, p < .001), and Emotional Representation (r = .61 to .74, p < .001). Furthermore, convergent validity has been demonstrated with standardized psychological scales: the B-IPQ Emotional Representation and Concern items correlate substantially with the Hospital Anxiety and Depression Scale (HADS; correlations ranging from r = .40 to .65) and the General Health Questionnaire (GHQ-12).

Discriminant Validity: The B-IPQ successfully distinguishes between medical conditions with differing pathophysiological characteristics. In Broadbent et al. (2006), patients with acute asthma reported significantly lower timeline scores (reflecting a more episodic or reversible trajectory) and higher personal control scores than patients undergoing chronic hemodialysis for end-stage renal disease (p < .001). Similarly, patients suffering from acute myocardial infarction demonstrated dramatic, clinically meaningful shifts in their illness perceptions following an in-hospital educational session, whereas control patients maintained static representations, demonstrating the instrument’s sensitivity to change.

Predictive Validity: The B-IPQ demonstrates robust predictive power across prospective longitudinal trials. In post-myocardial infarction cohorts, baseline B-IPQ scores significantly predicted return to work within three months, independent of objective markers of cardiac damage such as peak troponin levels or left ventricular ejection fraction. Specifically, patients holding high timeline and consequence beliefs were significantly less likely to resume full-time employment. In diabetic cohorts, higher personal control and treatment control scores have predicted improved glycemic control (HbA1c) at 6- and 12-month follow-ups, mediated by superior self-care adherence. Across broader chronic disease cohorts, higher composite threat scores systematically predict poorer functional status, lower quality of life, elevated healthcare utilization, and increased all-cause mortality.

Reliability

Because the B-IPQ utilizes single-item operationalizations for each distinct theoretical dimension of the Common-Sense Model, traditional measures of internal consistency—such as Cronbach’s alpha—are neither theoretically nor mathematically appropriate when evaluating the separate subscales. Internal consistency metrics presume that multiple items within a scale represent parallel indicators of a single underlying latent construct. In contrast, the dimensions of the B-IPQ (e.g., timeline versus treatment control) are conceptually distinct and intentionally heterogeneous.

Consequently, empirical validation of the B-IPQ relies primarily upon test-retest reliability to establish temporal stability. In the initial validation cohort of outpatients with stable chronic renal disease, Broadbent et al. (2006) evaluated test-retest reliability across three-week and six-week intervals. Pearson correlation coefficients demonstrated good to excellent stability across all single items:

• Consequences: r = .65 (3-week) and .70 (6-week)
• Timeline: r = .67 (3-week) and .73 (6-week)
• Personal Control: r = .57 (3-week) and .59 (6-week)
• Treatment Control: r = .48 (3-week) and .53 (6-week)
• Identity: r = .61 (3-week) and .64 (6-week)
• Concern: r = .71 (3-week) and .75 (6-week)
• Understanding/Coherence: r = .48 (3-week) and .52 (6-week)
• Emotional Representation: r = .72 (3-week) and .75 (6-week)

Subsequent psychometric investigations in translated editions (including Spanish, Dutch, German, Persian, Mandarin, Turkish, and Scandinavian adaptations) have yielded comparable test-retest intraclass correlation coefficients (ICCs), generally ranging between .60 and .85 across intervals from 14 to 30 days. When researchers calculate an overall illness threat composite score (combining all eight items after reverse-scoring protective dimensions), internal consistency analysis has occasionally yielded Cronbach’s alpha coefficients between .70 and .82, indicating adequate structural coherence of the total threat construct in specific patient populations.

Factor Analysis

The structural dimensionality of the B-IPQ has been subjected to both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) across diverse medical cohorts. Although the original developers intended each item to be analyzed as an autonomous, single-item indicator representing a distinct theoretical facet of Leventhal’s CSM, subsequent psychometric investigations have frequently explored whether these eight continuous items coalesce into higher-order latent factors.

In various empirical evaluations, factor analytic procedures have repeatedly revealed a two-factor or three-factor latent architecture:

• Two-Factor Model (Cognitive Competence vs. Emotional Threat):
  • Factor 1: Cognitive Illness Threat / Illness Impact — Marked by high positive factor loadings from Consequences (Item 1, loadings .65–.85), Identity (Item 5, loadings .60–.80), Concern (Item 6, loadings .68–.88), and Emotional Representation (Item 8, loadings .70–.89). This factor reflects the perceived severity, burden, and emotional distress of the disease.
  • Factor 2: Controllability / Coping Competence — Marked by high positive loadings from Personal Control (Item 3, loadings .60–.82), Treatment Control (Item 4, loadings .55–.78), and Illness Comprehensibility (Item 7, loadings .45–.70). This factor represents the patient’s perceived capacity to understand and manage the illness.
• Three-Factor Alternative: In some cohorts (e.g., chronic pain, oncology), CFA demonstrates superior fit indices when decomposing the instrument into: (1) Cognitive Threat (Consequences, Timeline, Identity); (2) Emotional Threat (Concern, Emotional Representation); and (3) Controllability & Comprehensibility (Personal Control, Treatment Control, Understanding). Typical model fit parameters for this three-factor representation report acceptable to excellent goodness-of-fit indices across published structural equation models: Comparative Fit Index (CFI) > .92, Tucker-Lewis Index (TLI) > .90, and Root Mean Square Error of Approximation (RMSEA) < .06 to .08.

Despite the viability of higher-order composite scores, the original authors and psychometric guidelines caution that collapsing items into single aggregate metrics can obscure clinically critical nuances. For example, a patient may register moderate overall threat because of high treatment efficacy beliefs alongside profound emotional panic. Analyzing items individually preserves the discrete functional information essential for targeted clinical intervention.

Instrument / Measurement Tool

• Instrument Name: Brief Illness Perception Questionnaire (B-IPQ)
• Acronym: B-IPQ
• Construct Measured: Cognitive and emotional representations of illness, personal/treatment control appraisals, and perceived illness causality
• Theoretical Framework: Leventhal’s Common-Sense Model of Self-Regulation (CSM)
• Test Type: Patient-Reported Outcome Measure (PROM) / Psychological Screener
• Format: Paper-and-pencil questionnaire, digital survey (web/mobile), or clinician-administered interview
• Item Count: 9 items total (8 quantitative continuous rating items + 1 open-ended qualitative causal item)
• Response Scale:
  • Items 1–8: 0 to 10 numerical rating scale with item-specific semantic endpoints:
  • Item 1: 0 = ‘no affect at all’ to 10 = ‘severely affects my life’
  • Item 2: 0 = ‘a very short time’ to 10 = ‘forever’
  • Item 3: 0 = ‘absolutely no control’ to 10 = ‘extreme amount of control’
  • Item 4: 0 = ‘not at all’ to 10 = ‘extremely helpful’
  • Item 5: 0 = ‘no symptoms at all’ to 10 = ‘many severe symptoms’
  • Item 6: 0 = ‘not at all concerned’ to 10 = ‘extremely concerned’
  • Item 7: 0 = ‘don’t understand at all’ to 10 = ‘understand very clearly’
  • Item 8: 0 = ‘not at all affected emotionally’ to 10 = ‘extremely affected emotionally’
  • Item 9: Open-ended qualitative listing format asking respondents to list and rank-order the three most important factors they believe caused their illness.
• Administration Time: Approximately 3 to 5 minutes
• Scoring Rules:
  • Dimensional Profile: Each item (1 through 8) is scored directly as an autonomous dimension reflecting: Consequences (Item 1), Timeline (Item 2), Personal Control (Item 3), Treatment Control (Item 4), Identity (Item 5), Concern (Item 6), Coherence/Understanding (Item 7), and Emotional Response (Item 8).
  • Overall Illness Threat Score: An overall composite threat score can be computed to capture the degree to which the illness is perceived as threatening or benign. To compute this score:
    • Reverse-score Personal Control (Item 3): New Item 3 Score = 10 – Original Item 3 Score
    • Reverse-score Treatment Control (Item 4): New Item 4 Score = 10 – Original Item 4 Score
    • Reverse-score Understanding (Item 7): New Item 7 Score = 10 – Original Item 7 Score
    • Sum the values of Items 1, 2, Reversed Item 3, Reversed Item 4, 5, 6, Reversed Item 7, and 8.
    • The resulting total composite score ranges from 0 to 80, where a higher total score indicates a more threatening, pessimistic view of the illness.
  • Causal Analysis (Item 9): Qualitative responses are analyzed using categorical content analysis, coding responses into recognized causal groups (e.g., stress, hereditary/genetics, environmental causes, lifestyle/diet, aging, emotional state, or chance).

Permissions & Fee and Test Year

The Brief Illness Perception Questionnaire was formally published in 2006 in the Journal of Psychosomatic Research. In alignment with the developers’ commitment to advancing clinical care and health psychology research, the B-IPQ is placed in the public domain for academic, non-commercial research, and clinical practice purposes. No licensing fees or formal written permissions are required from the authors for non-profit academic research, university dissertations, or routine clinical healthcare monitoring.

Researchers and clinicians are permitted to adapt the specific illness descriptor within the item stems (e.g., replacing the generic phrase “your illness” with “your diabetes”, “your heart disease”, or “your chronic pain”) to maximize contextual relevance for specific medical conditions. When utilizing the B-IPQ in published academic manuscripts, proper citation of the seminal validation article (Broadbent et al., 2006) is required. For commercial clinical trials, pharmaceutical sponsor-funded protocols, or inclusion in proprietary software platforms, commercial licensing policies may apply, and interested parties should contact the corresponding author, Prof. Elizabeth Broadbent at the University of Auckland.

References

• Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006). The Brief Illness Perception Questionnaire. Journal of Psychosomatic Research, 60(6), 631–637. https://doi.org/10.1016/j.jpsychores.2005.10.020
• Broadbent, E., Wilkes, C., Koschwanez, H., Weinman, J., Norton, S., & Petrie, K. J. (2015). A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychology & Health, 30(11), 1361–1385. https://doi.org/10.1080/08870446.2015.1070851
• Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense representation of illness danger. In S. Rachman (Ed.), Contributions to Medical Psychology (Vol. 2, pp. 7–30). Pergamon Press.
• Leventhal, H., Phillips, L. A., & Burns, E. (2016). The Common-Sense Model of Self-Regulation (CSM): A dynamic framework for understanding illness self-management. Journal of Behavioral Medicine, 39(6), 935–946. https://doi.org/10.1007/s10865-016-9782-2
• Moss-Morris, R., Weinman, J., Petrie, K., Horne, R., Cameron, L., & Buick, D. (2002). The Revised Illness Perception Questionnaire (IPQ-R). Psychology & Health, 17(1), 1–16. https://doi.org/10.1080/08870440290001494
• Petrie, K. J., Jago, L. A., & Devcich, D. A. (2007). The role of illness perceptions in patients with medical conditions. Current Opinion in Psychiatry, 20(2), 163–167. https://doi.org/10.1097/YCO.0b013e328014a871
• Weinman, J., Petrie, K. J., Moss-Morris, R., & Horne, R. (1996). The Illness Perception Questionnaire: A new measure for assessing the cognitive representation of illness. Psychology & Health, 11(3), 431–445. https://doi.org/10.1080/08870449608400270

13. Items of the Scale (Questionnaire)